Doctors are calling on all parties to reject the Pharmacy Guild’s push to expand Victoria’s Chemist Care Now program to conditions such as asthma, high blood pressure, and type 2 diabetes.
AMA Victoria President Simon Judkins raised significant questions following reports that Deloitte Access Economics modelling commissioned by the Guild estimates an expanded program could free up as many as 79,000 public hospital bed days each year.
“The Guild paid for modelling to make the case for expansion. It got a headline that makes that case. Now let’s see the full modelling, the assumptions, and the evidence behind them.
“Which hospital admissions does the model assume would be prevented? On what evidence? And would investing the same money in GP access achieve more?
“Everyone claims their proposal will reduce emergency department presentations and take pressure off hospitals, but that doesn’t make it true.
“If the Guild is so confident in its numbers, they should be willing to share the data with other health bodies, including the AMA, and governments need to be doing their own independent analysis, not just accepting these claims at face value.”
Dr Judkins said the proposal went well beyond helping patients with minor ailments and raised serious questions about patient safety and continuity of care.
“Managing diabetes or high blood pressure is about more than writing a prescription. It means understanding the whole patient and making sure they get the tests, monitoring, and follow-up they need.
“An economic projection doesn’t tell us whether a diagnosis was missed, whether a patient got the follow-up they needed, or whether they ended up in hospital anyway. That’s why an independent clinical evaluation is required.
“Pharmacists are valued, colleagues. We work with them every day to keep patients safe. But when the same business decides whether a medicine is needed and profits from selling it, there’s an inherent conflict of interest. Clinical protocols don’t remove it.”
AMA Victoria welcomed clarification from Georgie Crozier’s office this morning that support for expanding pharmacy prescribing for asthma, high blood pressure, and type 2 diabetes, attributed to the Coalition in media reporting, does not reflect the Victorian Liberal Party’s position.
As part of its election priorities, AMA Victoria is calling on the next Victorian Government to reverse recent expansions of pharmacist prescribing under Chemist Care Now, rule out further expansion, strengthen access to GP-led care, and publish an independent clinical evaluation of the program.
That evaluation must examine actual patient outcomes, including safety and continuity of care, as well as the overall cost to the health system.
“If patients are going to hospital because they can’t get in to see a GP, that’s a reason to make it easier to see a GP”, said Dr Judkins.